Skip to content

2026 Best Places to Work - Learn More

  • News & Resources
  • Contact
Eyepoint logo link to home.
  • Science & Technology
  • Our Programs
  • About Us
  • Working At EyePoint
  • Investors
  • Science & Technology
  • Our Programs
  • About Us
  • Working At EyePoint
  • Investors
  • News & Resources
  • Contact

Press Releases

  • Press Releases
  • In The News
  • Scientific Publications
Newest First
  • Newest First
  • Oldest First
All Years
  • All Years
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
Press Release
November 6, 2026

EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings

Press Release
November 5, 2026

EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026

Press Release
October 19, 2026

EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD

Press Release
October 19, 2026

EyePoint Announces Strategic Prioritization

Press Release
September 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Press Release
September 2, 2026

EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting

Press Release
August 17, 2026

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

Press Release
August 14, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Press Release
August 5, 2026

EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments

Press Release
July 30, 2026

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

1 2 3 … 61 Next
Displaying 1-10 of 610
Eyepoint logo link to home.

Headquarters
480 Pleasant Street, Suite C-400
Watertown, MA 02472

Manufacturing
600 Commerce Drive
Northbridge, MA 01534

1-833-EYEPOINT (1.833.393.7646)

2026 Best Places to Work
  • Science & Technology
  • Our Programs
  • About Us
  • Working At EyePoint
  • Investors
  • News & Resources
  • Contact
  • Terms and Conditions
  • Privacy Policy
  • Cookies Notice
  • Cookie Settings
  • Compliance
  • Terms and Conditions
  • Privacy Policy
  • Cookies Notice
  • Cookie Settings
  • Compliance

© 2026 EyePoint, Inc. All Rights Reserved

DURASERT®, DURASERT E™, DURAVYU™, EyePoint®, and the EyePoint Logo® are trademarks of EyePoint or its subsidiary.